Hamid Farhangi
Overview
Explore the profile of Hamid Farhangi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amirfiroozy A, Naghinejad M, Rezamand A, Farhangi H, Golchehre Z, Jalali H, et al.
Mol Cell Probes
. 2025 Jan;
79:102014.
PMID: 39875016
Osteopetrosis is a group of genetically and clinically diverse inherited disorders characterized by an increase in bone density. The main known cause is an abnormality in the development or function...
2.
Golestan Kalateh S, Rajaei A, Farhangi H, Bayazi M
J Educ Health Promot
. 2024 Sep;
13:190.
PMID: 39268426
Background: Examining the psychological factors related to the disease and their treatment can be important. The present study was carried out with the aim of the effectiveness of acceptance and...
3.
Saeedi A, Baghestani A, Khadem Maboudi A, Farhangi H
Iran J Med Sci
. 2020 Aug;
45(4):304-310.
PMID: 32801420
Acute lymphoblastic leukemia (ALL) is the most common cause of cancer-related fatality among children. This study aimed to identify the significant prognostic factors for the incidence of pediatric ALL. This...
4.
Kachooei A, Heidari A, Divband G, Zandinezhad M, Mousavian A, Farhangi H, et al.
Haemophilia
. 2019 Dec;
26(1):142-150.
PMID: 31814241
Introduction: Radiocolloids labelled with less costly and more accessible radionuclides such as rhenium-188 are of interest to developing countries compared with those labelled with rhenium-186 and yttrium-90. Aim: This study...
5.
Vazifeh Doust M, Hojjati H, Farhangi H
J Relig Health
. 2019 Jun;
59(6):2857-2865.
PMID: 31240515
Cancer is one of the chronic and rare diseases in children that is associated with psychological trauma that can cause fear and anxiety in patients. Considering that spirituality as a...
6.
Jaripour M, Hayatigolkhatmi K, Iranmanesh V, Khadivi Zand F, Badiei Z, Farhangi H, et al.
Mediterr J Hematol Infect Dis
. 2018 Jul;
10(1):e2018042.
PMID: 30002798
Background And Objective: β-thalassemia results from a diverse range of mutations inside the hemoglobin subunit β () gene. In a study of β-thalassemia carriers and some of their at-risk fetuses...
7.
Sharbaf F, Farhangi H, Assadi F
Int J Prev Med
. 2017 Nov;
8:76.
PMID: 29114374
Children with cancer treated with cytotoxic drugs are frequently at risk of developing renal dysfunction. The cytotoxic drugs that are widely used for cancer treatment in children are cisplatin (CPL),...
8.
Farhangi H, Silanian Toosi M, Alamdaran S, Bagheri S
Iran J Otorhinolaryngol
. 2017 Sep;
29(94):291-294.
PMID: 28955677
Introduction: Nasopharyngeal carcinoma (NPC) is a rare malignancy in children. Nasal obstruction, otitis media with effusion, pain in the ear, hearing problems, and unusual neck mass are among the signs...
9.
Farhangi H, Badiei Z, Moghaddam H, Keramati M
Indian J Hematol Blood Transfus
. 2017 Jun;
33(2):228-234.
PMID: 28596656
Accumulation of excess iron in heart can lead to cardiac dysfunction, which is the most common cause of death in thalassemia major patients. Biopsy is an invasive procedure and therefore...
10.
Moghaddam H, Badiei Z, Eftekhari K, Shakeri R, Farhangi H
Electron Physician
. 2015 Sep;
7(3):1102-7.
PMID: 26388975
Background: There are various clinical symptoms of thalassemia intermedia, and they lie roughly between those of major and minor forms of the disease. Patients with thalassemia intermedia occasionally require blood...